ResMed Inc. RMD.AX Stock
ResMed Inc. Price Chart
ResMed Inc. RMD.AX Financial and Trading Overview
ResMed Inc. stock price | 33.1 AUD |
Previous Close | 31.81 AUD |
Open | 31.79 AUD |
Bid | 31.7 AUD x 0 |
Ask | 31.79 AUD x 0 |
Day's Range | 31.7 - 31.95 AUD |
52 Week Range | 27.83 - 36.37 AUD |
Volume | 1.38M AUD |
Avg. Volume | 1.05M AUD |
Market Cap | 46.86B AUD |
Beta (5Y Monthly) | 0.480633 |
PE Ratio (TTM) | 36.860466 |
EPS (TTM) | 0.98 AUD |
Forward Dividend & Yield | 0.26 (0.82%) |
Ex-Dividend Date | May 10, 2023 |
1y Target Est | 36.37 AUD |
RMD.AX Valuation Measures
Enterprise Value | 20.18B AUD |
Trailing P/E | 36.860466 |
Forward P/E | 29.08257 |
PEG Ratio (5 yr expected) | 1.26 |
Price/Sales (ttm) | 11.670513 |
Price/Book (mrq) | 4.7373533 |
Enterprise Value/Revenue | 5.025 |
Enterprise Value/EBITDA | 16.097 |
Trading Information
ResMed Inc. Stock Price History
Beta (5Y Monthly) | 0.480633 |
52-Week Change | 11.34% |
S&P500 52-Week Change | 20.43% |
52 Week High | 36.37 AUD |
52 Week Low | 27.83 AUD |
50-Day Moving Average | 33.65 AUD |
200-Day Moving Average | 32.93 AUD |
RMD.AX Share Statistics
Avg. Volume (3 month) | 1.05M AUD |
Avg. Daily Volume (10-Days) | 1.29M AUD |
Shares Outstanding | 1.47B |
Float | 582.27M |
Short Ratio | N/A |
% Held by Insiders | 0% |
% Held by Institutions | 7.55% |
Shares Short | N/A |
Short % of Float | N/A |
Short % of Shares Outstanding | N/A |
Dividends & Splits
Trailing Annual Dividend Rate | 1.74 |
Trailing Annual Dividend Yield | 5.46% |
5 Year Average Dividend Yield | N/A |
Payout Ratio | 0.2969 |
Last Split Factor | 2:1 |
Financial Highlights
Fiscal Year
Fiscal Year Ends | June 30, 2022 |
Most Recent Quarter (mrq) | March 31, 2023 |
Next Fiscal Year End | June 30, 2023 |
Profitability
Profit Margin | 21.49% |
Operating Margin (ttm) | 27.92% |
Gross Margin | 57.00% |
EBITDA Margin | 31.21% |
Management Effectiveness
Return on Assets (ttm) | 12.06% |
Return on Equity (ttm) | 23.93% |
Income Statement
Revenue (ttm) | 4.02B AUD |
Revenue Per Share (ttm) | 6.85 AUD |
Quarterly Revenue Growth (yoy) | 29.19% |
Gross Profit (ttm) | 2.06B AUD |
EBITDA | 1.25B AUD |
Net Income Avi to Common (ttm) | 862.95M AUD |
Diluted EPS (ttm) | 0.86 |
Quarterly Earnings Growth (yoy) | 29.89% |
Balance Sheet
Total Cash (mrq) | 240.01M AUD |
Total Cash Per Share (mrq) | 0.41 AUD |
Total Debt (mrq) | 1.72B AUD |
Total Debt/Equity (mrq) | 43.84 AUD |
Current Ratio (mrq) | 3.069 |
Book Value Per Share (mrq) | 6.6915 |
Cash Flow Statement
Operating Cash Flow (ttm) | 535.35M AUD |
Levered Free Cash Flow (ttm) | 288.28M AUD |
Profile of ResMed Inc.
Country | Australia |
State | CA |
City | San Diego |
Address | 9001 Spectrum Center Boulevard |
ZIP | 92123 |
Phone | 858 836 5000 |
Website | https://www.resmed.com |
Industry | Medical Instruments & Supplies |
Sector(s) | Healthcare |
Full Time Employees | 8160 |
ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications for the healthcare markets. The company operates in two segments, Sleep and Respiratory Care, and Software as a Service. It offers various products and solutions for a range of respiratory disorders, including technologies to be applied in medical and consumer products, ventilation devices, diagnostic products, mask systems for use in the hospital and home, headgear and other accessories, dental devices, and cloud-based software informatics solutions to manage patient outcomes, as well as provides customer and business processes. The company also provides AirView, a cloud-based system that enables remote monitoring and changing of patients' device settings; myAir, a personalized therapy management application for patients with sleep apnea that provides support, education, and troubleshooting tools for increased patient engagement and improved compliance; U-Sleep, a compliance monitoring solution that enables home medical equipment (HME)to streamline their sleep programs; connectivity module and propeller solutions; and Propeller portal. It offers out-of-hospital software solution, such as Brightree business management software and service solutions to providers of HME, pharmacy, home infusion, orthotics, and prosthetics services; MatrixCare care management and related ancillary solutions to senior living, skilled nursing, life plan communities, home health, home care, and hospice organizations, as well as related accountable care organizations; and HEALTHCAREfirst that offers electronic health record, software, billing and coding services, and analytics for home health and hospice agencies. The company markets its products primarily to sleep clinics, home healthcare dealers, and hospitals through a network of distributors and direct sales force in approximately 140 countries. ResMed Inc. was founded in 1989 and is headquartered in San Diego, California.
Q&A For ResMed Inc. Stock
What is a current RMD.AX stock price?
ResMed Inc. RMD.AX stock price today per share is 33.1 AUD.
How to purchase ResMed Inc. stock?
You can buy RMD.AX shares on the ASX exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for ResMed Inc.?
The stock symbol or ticker of ResMed Inc. is RMD.AX.
Which industry does the ResMed Inc. company belong to?
The ResMed Inc. industry is Medical Instruments & Supplies.
How many shares does ResMed Inc. have in circulation?
The max supply of ResMed Inc. shares is 1.48B.
What is ResMed Inc. Price to Earnings Ratio (PE Ratio)?
ResMed Inc. PE Ratio is 33.77551000 now.
What was ResMed Inc. earnings per share over the trailing 12 months (TTM)?
ResMed Inc. EPS is 0.98 AUD over the trailing 12 months.
Which sector does the ResMed Inc. company belong to?
The ResMed Inc. sector is Healthcare.
ResMed Inc. RMD.AX included in indexes
Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
---|
Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
---|---|---|---|---|---|---|---|
{{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
S&P/ASX 300 AXKO | 7829.1 AUD 5181.75 USD |
+1.63
|
— — | 7703.9 AUD 5098.88 USD | 7847.4 AUD 5193.86 USD | — - | — — |
S&P/ASX 200 EQUAL WEIGHT AXEW | 1909.4 AUD 1263.75 USD |
+1.32
|
— — | 1884.6 AUD 1247.34 USD | 1914.9 AUD 1267.39 USD | — - | — — |
ALL ORDINARIES AORD | 8150.1 AUD 5394.2 USD |
+1.61
|
— — | 8020.9 AUD 5308.69 USD | 8167.3 AUD 5405.59 USD | — - | — — |
S&P/ASX 200 Net Total Rtn AXNT | 94865 AUD 62787.08 USD |
+1.65
|
— — | 93329.2 AUD 61770.6 USD | 95092.1 AUD 62937.39 USD | — - | — — |
S&P/ASX 200 AXJO | 7881.3 AUD 5216.29 USD |
+1.65
|
— — | 7753.7 AUD 5131.84 USD | 7900.2 AUD 5228.8 USD | — - | — — |
S&P/ASX 100 ATOI | 6615.9 AUD 4378.78 USD |
+1.69
|
— — | 6506 AUD 4306.04 USD | 6632 AUD 4389.44 USD | — - | — — |
S&P/ASX 50 AFLI | 7724.2 AUD 5112.32 USD |
+1.72
|
— — | 7593.7 AUD 5025.94 USD | 7744.2 AUD 5125.55 USD | — - | — — |
- {{ link.label }} {{link}}